Guardian July 6, 2024
Decision that overturned convention of deference to federal agencies could upend regulations on tobacco, drugs and medical bills.
A supreme court decision that overturned the “Chevron doctrine” could upend regulations on everything from tobacco to pharmaceuticals to surprise medical bills, experts told the Guardian.
The 40-year-old legal framework, the Chevron doctrine, once directed courts to defer to the expertise of federal agencies, such as the US Food and Drug Administration (FDA).
In a far-reaching decision, the court’s conservative supermajority held last week in Loper Bright Enterprises v Raimondo and Relentless Inc v Department of Commerce that the reverse should apply, with courts having the final say over even highly technical regulations.
Today's Sponsors
Today's Sponsor